Neuroendocrine Carcinoma Clinical Trials
2 recruiting trials for Neuroendocrine Carcinoma. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
1
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 1 / Phase 2NCT07038096
ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
This study is a randomized, multicenter, Phase Ib/II clinical trial, aimed at evaluating the efficacy and safety of the combination of ZG006 and ZG005 in patients with advanced...
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,LtdEnrolling: 3501 location
RECRUITINGPhase 3NCT06937905
Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic...
Based on the efficacy of tarlatamab in patients with small-cell lung cancer, we aim to assess the efficacy of tarlatamab in patients with Advanced, pulmonary (large-cell only) or...
Sponsor: Intergroupe Francophone de Cancerologie ThoraciqueEnrolling: 12920 locations